Abiopharma

🔍 Li Mengmeng (Executive)

Company: JinkoSolar Holding Co., Ltd. (JKS)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 2,856 shares of Ordinary Shares (represented by American Depositary Shares) (Direct)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 2,856.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each American Depositary Share ("ADS") represents four ordinary shares of the issuer, par value US$0.00002 per share.
• F2: Vesting of performance-based restricted shares. Each restricted share represents a contingent right to receive one ordinary share of the Issuer. These performance-based restricted shares were granted by the Issuer on January 5, 2023 pursuant to 2023 Equity Incentive Plan, which vested in full on May 1, 2026. These performance-based restricted shares are being reported for the first time on this Form 4 in connection with their vesting